| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | REVANCE THERAPEUTICS INC | 4,592,047 | 144,649,000 | 36.82% | ||
| 2 | Horizon Pharma Inc | 5,815,940 | 85,055,000 | 21.65% | ||
| 3 | ABIOMED INC | 3,150,000 | 82,026,000 | 20.88% | ||
| 4 | ENDOLOGIX INC | 1,165,428 | 51,550,000 | 13.12% | ||
| 5 | ACURA PHARMACEUTICALS INC | 10,294,886 | 14,282,000 | 3.64% | ||
| 6 | ZIOPHARM Oncology, Inc. | 2,764,908 | 11,799,000 | 3.00% | ||
| 7 | MEDICINOVA INC | 1,170,370 | 2,399,000 | 0.61% | ||
| 8 | CURIS INC | 233,797 | 659,000 | 0.17% | ||
| 9 | CHINA CORD BLOOD CORP | 86,763 | 347,000 | 0.09% | ||
| 10 | Echo Therapeutics Inc | 12,319 | 37,000 | 0.01% | ||
| 11 | PALATIN TECHNOLOGIES INC COM PAR $ .01 | 23,928 | 29,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-14-001037, filed 2014.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
